CME Outfitters Announces Upcoming neuroscienceCME Podcast Series: "Addressing Clinical Challenges in the Long-Term Treatment of Schizophrenia"

Share Article

Premiering Friday, February 22, 2008, at neuroscienceCME.com and the iTunes Podcast Directory, this multidisciplinary CE activity is specifically designed to apply concepts related to the long-term management of patients with schizophrenia and specifically in the areas of remission and recovery, metabolic consequences of atypical antipsychotics, and switching. "Addressing Clinical Challenges in the Long-Term Treatment of Schizophrenia" consists of three expert interviews hosted by Charles B. Nemeroff, MD, PhD.

CME Outfitters, LLC, an independent accredited provider of multidisciplinary medical education programming and related healthcare communications services, announces a neuroscienceCME podcast series titled "Addressing Clinical Challenges in the Long-Term Treatment of Schizophrenia."

Premiering Friday, February 22, 2008, at neuroscienceCME.com and the iTunes Podcast Directory, this multidisciplinary CE activity is specifically designed to apply concepts related to the long-term management of patients with schizophrenia and specifically in the areas of remission and recovery, metabolic consequences of atypical antipsychotics, and switching. This podcast series consists of three expert interviews hosted by Charles B. Nemeroff, MD, PhD. This activity is certified for one hour of multidisciplinary CE credit and will be offered until February 2009.

There is no fee to participate or receive CE credit for this activity; however, registration is required. There are two methods for registering for this special activity:
Online: Visit the activity details page at http://www.neuroscienceCME.com/PR296
Phone: Call 877.CME.PROS (877.263.7767).

Host:
Charles B. Nemeroff, MD, PhD
Reunette W. Harris Professor and Chairman
Department of Psychiatry and Behavioral Sciences
Emory University School of Medicine
Atlanta, GA

Guests:
Peter F. Buckley, MD
Professor and Chairman
Department of Psychiatry and Health Behavior
Medical College of Georgia
Augusta, GA

Stephen R. Marder, MD
Professor and Director, Section on Psychosis
Semel Institute of Neuroscience
David Geffen School of Medicine
University of California, Los Angeles
Director, VA Desert Pacific Mental Illness Research, Education, and Clinical Center
VA Greater Los Angeles
Los Angeles, CA

John W. Newcomer, MD
Professor of Psychiatry, Psychology, and Medicine
Medical Director, Center for Clinical Studies
Washington University School of Medicine
St. Louis, MO

Statement of Need:
Schizophrenia is a chronic debilitating condition affecting 2.2 million individuals in the United States and 51 million people worldwide. Expert panels recently have defined and operationalized remission and recovery as treatment targets. A number of considerations, including the pharmacology of the particular agent, its efficacy, safety, and tolerability, all must be balanced in selecting a long-term treatment plan. Particular attention must be paid to iatrogenic effects of the atypicals on cardiometabolic risk factors, and psychiatrists need to integrate screening and monitoring for such risks into their practice. Switching medications may be a necessity in patients with metabolic or other unwanted side effects from atypical antipsychotics, and it is important to understand when and how to switch medications. In this podcast series, experts will discuss remission and recovery as treatment goals, identification and management of metabolic concerns, and indications and methods for switching antipsychotics.
Module 1: Defining and Assessing Remission and Recovery
Module 2: Identifying and Managing the Iatrogenic Effects of Antipsychotic Medications on Weight Gain and Other Metabolic Parameters
Module 3: Indications and Methods for Switching Antipsychotic Medications

Learning Objectives:
At the end of this CE activity, participants should be able to:

  • Define and operationalize remission and recovery.
  • Apply data on weight gain in patients with schizophrenia to the development of an effective screening and monitoring plan.
  • Discuss clinical considerations involved in switching atypical antipsychotic medication.

Target Audience:
Physicians, physician assistants, nurses, nurse practitioners, psychologists, social workers, certified case managers, pharmacists, and other clinicians that participate in the long-term management of patients with schizophrenia.

Credit Information:
CME Credit (Physicians):
CME Outfitters, LLC, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. CME Outfitters, LLC, designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Note to Physician Assistants: AAPA accepts Category I credit from AOACCME, Prescribed credit from AAFP, and AMA Category I CME credit for the PRA from organizations accredited by ACCME.

CNE Credit (Nurses):
CME Outfitters, LLC, is an approved provider of continuing nursing education by the New York State Nurses Association, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation.

It has been assigned code 6WASUP-PRV-0632. 1.0 contact hours will be awarded upon successful completion.
Note to Nurse Practitioners: The content of this CNE activity pertains to Pharmacology.

CEP Credit (Psychologists):
CME Outfitters is approved by the American Psychological Association to sponsor continuing education for psychologists. CME Outfitters maintains responsibility for this program and its content. (1.0 CE credits)

NASW Credit (Social Workers):
This program was approved by the National Association of Social Workers (provider #886407722) for 1.0 continuing education contact hours.

CCMC Credit (Certified Case Managers):
This program has been approved for 1.0 hours by the Commission for Case Manager Certification (CCMC).

CPE Credit (Pharmacists):
CME Outfitters, LLC, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 1.0 contact hours (0.1 CEUs)
Universal Program Number: 376-000-08-008-H01-P

Post-tests and activity evaluations can be completed online at http://www.neuroscienceCME.com (click on the Testing/Certification link under the Resources tab - requires free account activation), and participants can print their certificate or statement of credit immediately (70% pass rate required).

About CME Outfitters:
CME Outfitters develops and distributes live, recorded, print, and web-based educational activities to thousands of clinicians each year and offers expert accreditation services for non-accredited organizations. For a complete catalog of certified activities, please visit http://www.cmeoutfitters.com, http://www.neuroscienceCME.com, or call 877.CME.PROS (877.263.7767).

About neuroscienceCME:
neuroscienceCME.com is the award-winning web portal serving clinicians, educators, and researchers in the neurosciences. Launched in October 2006, neuroscienceCME.com was custom designed to fill an identified gap in online resources for professionals around the world who are practicing in areas related to psychiatry, sleep disorders, addiction and substance abuse, ADHD, and other areas related to brain function. The site's primary mission is to be the professional's central forum for accessing, debating, synthesizing, and implementing the latest findings and best practices in the neurosciences.

To view all recent neuroscienceCME press releases, visit http://www.neuroscienceCME.com and click on "News Room" or visit http://www.prweb.com and search for "neuroscienceCME."

Clinical Compass, a bi-weekly e-newsletter published by CME Outfitters, is a convenient way to stay informed of all neuroscienceCME news and information. To subscribe, visit http://www.neuroscienceCME.com and click on "Subscribe to Clinical Compass."

Contact: Christopher Perez
CME Outfitters, LLC
240.243.1303 direct
240.243.1033 fax

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Christopher Perez
Visit website